We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$3.3B
AUM Growth
+$481M
Cap. Flow
+$53.5M
Cap. Flow %
1.62%
Top 10 Hldgs %
30.72%
Holding
1,380
New
403
Increased
148
Reduced
186
Closed
428

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.53%
2 Healthcare 3.46%
3 Communication Services 1.55%
4 Technology 0.91%
5 Consumer Discretionary 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AES icon
351
AES
AES
$10.6B
$1.6M 0.05%
70,000
-30,000
-30% -$729K
ASND icon
352
PUT
Ascendis Pharma A/S
ASND
$15.8B
$1.59M 0.05%
10,000
ALLK
353
PUT
DELISTED
Allakos
ALLK
$1.59M 0.05%
+15,000
New +$1.34M
V icon
354
PUT
Visa
V
$701B
$1.56M 0.05%
7,000
-4,000
-36% -$938K
TEVA icon
355
Teva Pharmaceuticals
TEVA
$45.7B
$1.56M 0.05%
160,000
AVPT icon
356
CALL
AvePoint
AVPT
$2.88B
$1.56M 0.05%
183,400
-56,600
-24% -$563K
SBUX icon
357
CALL
Starbucks
SBUX
$110B
$1.55M 0.05%
+14,100
New +$1.65M
YETI icon
358
PUT
Yeti Holdings
YETI
$2.88B
$1.54M 0.05%
18,000
KRYS icon
359
CALL
Krystal Biotech
KRYS
$9.97B
$1.54M 0.05%
+29,500
New +$1.75M
KURA icon
360
CALL
Kura Oncology
KURA
$1.01B
$1.54M 0.05%
82,000
+47,000
+134% +$886K
INCY icon
361
Incyte
INCY
$24.7B
$1.51M 0.05%
+22,000
New +$1.67M
QNCX icon
362
PUT
Quince Therapeutics
QNCX
$29.3M
$1.51M 0.05%
+83
New +$1.32M
VTRS icon
363
PUT
Viatris
VTRS
$19.1B
$1.51M 0.05%
111,600
+18,000
+19% +$255K
NTNX icon
364
PUT
Nutanix
NTNX
$18.4B
$1.51M 0.05%
+40,000
New +$1.51M
HYZN
365
CALL
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$1.51M 0.05%
+4,340
New +$1.88M
AUPH icon
366
Aurinia Pharmaceuticals
AUPH
$2.15B
$1.5M 0.05%
68,000
+58,000
+580% +$920K
VRRM icon
367
CALL
Verra Mobility
VRRM
$538M
$1.5M 0.05%
+99,500
New +$1.52M
WDAY icon
368
Workday
WDAY
$46B
$1.5M 0.05%
+6,000
New +$1.49M
AMD icon
369
CALL
Advanced Micro Devices
AMD
$823B
$1.49M 0.05%
14,500
+4,000
+38% +$409K
FATE icon
370
CALL
Fate Therapeutics
FATE
$282M
$1.48M 0.04%
+25,000
New +$1.96M
FATE icon
371
PUT
Fate Therapeutics
FATE
$282M
$1.48M 0.04%
+25,000
New +$1.96M
DPZ icon
372
CALL
Domino's
DPZ
$10.3B
$1.48M 0.04%
+3,100
New +$1.57M
PRU icon
373
Prudential Financial
PRU
$41.2B
$1.47M 0.04%
14,000
-4,500
-24% -$464K
PSX icon
374
Phillips 66
PSX
$106B
$1.47M 0.04%
+21,000
New +$1.52M
DNMR
375
CALL
DELISTED
Danimer Scientific, Inc.
DNMR
$1.47M 0.04%
+2,250
New +$1.65M

Similar funds

SG3 Management's Q3 2021 Portfolio in Review

As of Q3 2021, SG3 Management held 1,380 positions worth $3.3B, up 17% from $2.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

SG3 Management's Q3 2021 filing shows 403 new, 148 increased, 186 reduced and 428 closed positions. Its largest new stake was Alphabet (Google) Class C: 300,000 shares worth $40M. The largest sale was Alphabet (Google) Class A, an estimated $24.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 92% a quarter earlier, followed by Healthcare and Communication Services.

  • SG3 Management's largest Q3 2021 buy was Alphabet (Google) Class C: 300,000 shares worth $40M.
  • SG3 Management added most to Bausch Health in Q3 2021, an estimated $7.4M increase.
  • SG3 Management's biggest Q3 2021 reduction was Bank of America, cutting an estimated $4.85M.
  • SG3 Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $24.4M.
  • SG3 Management's ten largest holdings make up 31% of its $3.3B portfolio in Q3 2021.
  • SG3 Management opened 403 new positions and closed 428 in Q3 2021.
  • SG3 Management's portfolio value rose 17% quarter-over-quarter to $3.3B.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.